We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A monoclonal antibody developed by Washington-based Omeros helped in the recovery of six hospitalized COVID-19 patients given the treatment in a compassionate use program, the company said. Read More
The World Health Organization (WHO) will need $100 billion to pay for COVID-19 vaccines but it has only received commitments for 10 percent of that amount, according to the organization’s Director General Tedros Adhanom Ghebreyesus. Read More
China-based CanSino Biologics is preparing a phase 3 trial of its COVID-19 vaccine in Saudi Arabia, the country’s Ministry of Health has announced. Read More
Gilead Sciences announced yesterday that it has filed a new drug application (NDA) with the FDA, seeking approval for remdesivir for the treatment of COVID-19 patients. Read More
The Trump administration has said that the Department of Defense (DOD) will take the lead in distributing the COVID-19 vaccines secured under Operation Warp Speed, but some lawmakers are concerned that the administration has not yet released details of how that will be done. Read More
The Serum Institute of India has partnered with the Bill & Melinda Gates Foundation and Gavi, the Vaccine Alliance to manufacture 100 million doses of COVID-19 vaccines for low- and middle- income countries. Read More
Maryland-based Novavax has teamed up with Takeda Pharmaceutical Co. to commercialize Novavax’s COVID-19 vaccine candidate NVX-CoV2373 in Japan. Read More